Changes

Jump to: navigation, search

Veterinary Vaccines Market Report

1,972 bytes added, 12:03, 2 June 2014
/* Indian Veterinary Vaccines Market */
The global following report studies the Veterinary Vaccines market ($4.23 Bn) accounted for around 20% of in detail and analyzes the total Vaccines market ($29.71 Bn) in 2010. It is expected information to grow come up with a CAGR of 5.80% to reach the market size of $5.6 Bn by 2015. United States represents the largest market for Veterinary vaccines worldwide, with the market share of 46% Future trends and market size of $1.94 Bn Attractive segments in 2010. Porcine vaccines is the largest sub-segment in the Veterinary Vaccines this market which is forecasted to grow to $1.32 Bn market by 2015 whereas Canine Vaccines is the fastest growing segment among all the sub-segments with the growth rate of 5.81%.
The top 3 players in the Veterinary Vaccines market are Pfizer, Merck and Sanofi-Aventis, based on the revenues they generated in the Animal Health Segment in 2010. The report contains the company profile of 8 major players in this segment, with focus on their Veterinary Vaccines market activities only. There have been 11 Mergers/Acquisitions in the Veterinary Vaccines market in the last two years (2009-2011), with Pfizer acquiring Wyeth being the largest aquisition based on the deal size and the value add, it brought to Pfizer in the Veterinary Vaccines market and its portfolio. This acquisition has been analyzed in the market report.
Based on the market analysis, R&D trends, future focus areas of the key players and transactional activities in this segment, trends for the future with key focus areas have been analyzed.
The following is a snapshot of the complete report:
* The '''Global Veterinary Vaccines market ($4.23 Bn)''' accounted for around 20% of the total Vaccines market ($29.71 Bn) in 2010. It is expected to grow with a '''CAGR of 5.80%''' to reach the market size of '''$5.6 Bn by 2015'''.
* '''United States''' represents the largest market for Veterinary vaccines worldwide, with the market share of 46% and market size of $1.94 Bn in 2010.
* '''Porcine vaccines''' is the '''largest sub-segment''' in the Veterinary Vaccines market which is forecasted to grow to $1.32 Bn market by 2015 whereas '''Canine Vaccines''' is the '''fastest growing segment''' among all the sub-segments with the growth rate of 5.81%.
* The '''top 3 players''' in the Veterinary Vaccines market are '''Pfizer, Merck and Sanofi-Aventis''', based on the revenues they generated in the Animal Health Segment in 2010.
* The report contains the company profile of 8 major players in this segment, with focus on their Veterinary Vaccines market activities only.
* There have been '''11 Mergers/Acquisitions''' in the Veterinary Vaccines market in the last two years (2009-2011), with Pfizer acquiring Wyeth being the largest aquisition based on the deal size and the value add, it brought to Pfizer in the Veterinary Vaccines market and its portfolio. This acquisition has been analyzed in the market report.
 
 
Based on the market analysis, R&D trends, future focus areas of the key players and transactional activities in this segment, we conclude the following trends in the Veterinary Vaccines market:
# '''Companion Veterinary Vaccines''' are trailing on '''''high growth track'''''
#* Livestock Vaccines market is more developed than Companion Vaccines market right now, but the later is catching up very quickly with more number of clinical trials in the Companion Vaccines area
#* In companion vaccines, '''canine vaccines''' is forecasted to grow at the highest pace and is '''''expected to be the leading segment''''' in the Veterinary Vaccines market
# '''Two major segments in focus:'''
#* Canine
#* Porcine
# '''Two major areas of focus''' in the Veterinary vaccines market are:
#* Parasiticides
#* Infectious disease vaccines (Bacteria and Virus Vaccines)
 
<br>
=Introduction=
Vaccination protects hundreds of millions of animals worldwide from disease and possibly death. Animals, just like humans, suffer from a range of infectious diseases. As veterinary medicine has advanced, prevention of disease has become a priority as healthy food comes from healthy animals. One of the best means of preventing disease is by creating immunity in the animal. This is usually achieved by vaccination.
[[Image:Global Vaccines Market Size1.jpg|center|thumb|592px|Source: Dolcera Analysis]]
<br>
 
===Indian Veterinary Vaccines Market===
* The Indian veterinary vaccine market has reached $107M in 2011 and is forecast to reach $174M by 2020 with a CAGR of 5%.
* The animal vaccines include poultry vaccines,cattle and sheep vaccines.
* The main players in this sector include
** [http://www.indimmune.com/ Indian Immunologicals]
** [http://www.indovax.com/ Indovax]
** Intervet acquired by Merck
** [http://www.biovet.com/ Biovet]
** [http://www.hesterbiosciences.co.in/ Hester Biosciences]
** [http://www.brilliantbiopharma.com/ Brilliant Bio Pharma]
** [http://www.msd-animal-health.co.in/ MSD Animal Health (Merck)] and
** [http://iahvb.co.in/ The Institute of Animal Health and Veterinary Biologicals]
 
Source: Dolcera Analysis
 
[[Image:Indian Vaccines Market Size.jpg|center|thumb|592px|Source: Dolcera Analysis]]
<br>
<br>
* '''Livestock mainly Vaccines:''' Mainly consists of Farm animals like Cattle, pigs, sheep, poultry, aquaculture and bees.* '''Companion Animals mainly :''' Mainly consist of Dogs, cats and horses.
<br>
[[Image:Market Segmentation of Veterinary Vaccines1.jpg|center|thumb|591px|Source: Dolcera Analysis]]
'''''Please click on the segments in the pie-chart to get the corresponding segment forecast for 2010-2015'''''
{|align = "center"
|<gflash>900 500 http://dolcera.com/upload/files/Market_Segment_ForecastMarket_Segment_Forecast1_01.swf</gflash>
|-
|}
|}
<br>
 
Source: Company Annual Reports
== Comparative Analysis of Key Players ==
{|align = "center"
|<gflash>900 500 http://dolcera.com/upload/files/Comparative_Analysis3_01Comparative_Analysis3_02.swf</gflash>
|-
|}
#* Parasiticides
#* Infectious disease vaccines (Bacterian and Virus Vaccines)
 
Source: Company literature, databases, investment reports, and medical and business journals
<br>